why choose us

Clinical Trials Search

Showing 17,100 of 132,963 result(s)
A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects

Status: COMPLETED

Condition: Healthy Volunteer Study

Interventions: Oxytocin given by intravenous route

Date: 2022-12-20

A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

Status: COMPLETED

Condition: Healthy Participants

Interventions: Specified dose on specified days

Date: 2022-12-20

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

Status: Completed

Condition: Thyroid Cancer

Interventions: Selpercatinib Oral, twice daily during initial treatment period (28 Days).
A second course of selpercatinib if the participant is demonstrating c

Date: 2022-12-20

Double Voiding and Post-transplant UTI

Status: Completed

Condition: Urinary Tract Infections

Interventions: Participant will be instructed to void twice.

Date: 2022-12-20

Responder-derived FMT (R-FMT) and Pembrolizumab in Relapsed;Refractory PD-L1 Positive NSCLC

Status: NOT_YET_RECRUITING

Condition: Non Small Cell Lung Cancer

Interventions: FMT is a procedure in which fecal matter or stool is collected from a tested donor, mixed with a saline or other solution, strained and infused into t

Date: 2022-12-20

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

Status: Completed

Condition: Plasma Cell Myeloma

Interventions: Route of administration: IV infusion Pharmaceutical form: Vial

Date: 2022-12-20

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

Status: Completed

Condition: Cardiovascular Disease

Interventions: Participants will receive 2.4 mg cagrilintide s.c.
once-weekly after a dose escalation period of 16 weeks for 219 weeks.

Date: 2022-12-20

Longitudinal Spatial Frequency Domain Imaging Study

Status: Completed

Condition: Systemic Scleroderma

Interventions: SFDI is a method using near-infrared (NIR) light to generate wide field images (>10 x 10 cm) of tissue optical properties (absorption and scatterin

Date: 2022-12-20

Pyrimethamine as an Inhibitor of NRF2 in HPV-negative Locally Advanced Head and Neck Squamous Cell Carcinoma

Status: Completed

Condition: Head and Neck Cancer

Interventions: Patients will be instructed to take their dose at approximately the same time each day.

Date: 2022-12-20

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

Status: Completed

Condition: Psoriatic Arthritis

Interventions: Guselkumab (GUS) subcutaneous injection

Date: 2022-12-20